Goodwin Life Sciences Regulatory & Compliance partner Matt Wetzel has been named the 2023 recipient of the Patricia T. Meador Leadership Award by the American Health Law Association (AHLA), where he serves on the Board of Directors. The award is presented annually to AHLA member-volunteers who demonstrate extraordinary commitment and dedication to fraud and compliance educational efforts and mentoring. Wetzel was honored for the award at the AHLA’s Fraud & Compliance Forum in Baltimore, MD on September 27, 2023.
Co-leader of the firm’s Medtech practice and co-chair of its Late Stage Drug Development practice, Wetzel provides strategic counseling to pharmaceutical, medtech, diagnostic, and other life sciences and healthcare companies on a host of complex health laws and regulations, including federal and state fraud and abuse laws, market access and compliance issues, patient privacy obligations, and transparency requirements, among other areas. He serves as Goodwin’s expert on the Inflation Reduction Act.
AHLA highlighted Wetzel’s 360-degree perspective of the legal and compliance issues affecting his clients. Prior to joining Goodwin, he served as Chief Compliance Officer of GRAIL, Silicon Valley diagnostic testing company; Deputy General Counsel of AdvaMed, the world’s largest medical technology trade association in Washington, DC; and held an executive legal role at Boston Scientific.
Wetzel is also the featured Medtech & Life Sciences expert contributor to the Washington Legal Foundation where he writes about life sciences, medtech regulation, pharmaceutical issues, healthcare law, and government regulation. He hosts a regular podcast on healthcare fraud for AHLA, and he serves on the Editorial Board of the Policy & Medicine Compliance Update, a monthly periodical for life sciences lawyers on current enforcement and regulatory issues.
Committed to the medical technology community, Wetzel founded and co-chairs the AdvaMed PRIDE Leadership Network, a diversity and inclusion initiative with a mission focused on developing a more diverse future and spotlighting out-and-open LGBTQ leaders and executives in the medical technology industry. He also serves on the Board of the World War II Foundation.